Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore

Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore

10.1016/j.vaccine.2021.03.040

Saved in:
Bibliographic Details
Main Authors: Phua, LC, Choi, HCW, Wu, J, Jit, M, Low, J, Ng, K, Pearce, F, Hall, C, Abdul Aziz, MI
Other Authors: DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
Format: Article
Published: Elsevier BV 2021
Subjects:
Bivalent vaccine
Cervical cancer
Cost-effectiveness
Human papillomavirus
Nonavalent vaccine
Transmission dynamic model
Adolescent
Cost-Benefit Analysis
Female
Humans
Papillomavirus Infections
Papillomavirus Vaccines
Quality-Adjusted Life Years
Singapore
Uterine Cervical Neoplasms
Vaccination
Online Access:https://scholarbank.nus.edu.sg/handle/10635/206124
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

https://scholarbank.nus.edu.sg/handle/10635/206124

Similar Items